A single MXene-based optical gate switches between seven Boolean logic functions via voltage, enabling trainable photonic ...

Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation ...

Physicists have directly tracked tiny points of darkness in laser light racing faster than light itself, without breaking ...

Researchers developed a holographic data storage approach that stores and retrieves information in three dimensions by ...

A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...

A study reveals high-dose influenza vaccines could modestly reduce Alzheimer's risk in older adults, especially women, ...

Hans-Gerd Janssen reflects on the importance of the Riva Conference conference to advance his expertise in separation science ...

A new programmable metasurface performs dynamic beamforming and radar cross-section reduction across five frequency bands in a design 87% thinner than conventional approaches.

Discusses Preliminary Phase I/II Data for SRP-1001 in FSHD1 and SRP-1003 in DM1 March 25, 2026 8:30 AM EDT Anupam Rama - JPMorgan Chase & Co, Research Division Konstantinos Biliouris - Oppenheimer & ...

USA: Researchers have found in a new study that treatment with Anifrolumab significantly reduced urinary biomarkers of renal histologic activity in patients with Lupus Nephritis compared with placebo.

This strategic partnership with WuXi XDC represents a major milestone for Akari and a powerful validation of our novel PH1 ...

So now Brii has also expanded its discovering pipeline. What's the development strategy of Brii on its discovery programs? Will the company carry on the program to the late-stage development by itself ...